AstraZeneca (AZN)

3,250.50p
   
  • Change Today:
      4.00p
  • 52 Week High: 3,521.50p
  • 52 Week Low: 2,683.00p
  • Currency: UK Pounds
  • Shares Issued: 1,252.09m
  • Volume: 1,587,217
  • Market Cap: £40,699m
  • RiskGrade: 77
  • Beta: 0.69

Key dates

Dividend  
Latest XD Date (2nd Interim) 13-Feb-2013
Latest Pay Date (2nd Interim) 18-Mar-2013
   
Meetings  
AGM 25-Apr-2013
EGM n/a
GMs n/a
   
Announcements  
Trading announcement n/a
IMSs n/a
Drilling Report n/a
   
Results  
Final results 31-Jan-2013
Interim results 01-Aug-2013
Q1 Results 25-Apr-2013
Q2 Results 01-Aug-2013
Q3 Results 31-Oct-2013
Q4 Results 31-Jan-2013
Annual Report 25-Mar-2013
   
Year End 31-Dec-2013

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Forecast figures based on normalised accounts.

 

IFRS Changes - Find Out More

Find out about IFRS and how this affects the financial infomation for all UK companies.

AstraZeneca Market Data

Currency UK Pounds
Share Price 3,250.50p
Change Today 4.00p
% Change 0.12 %
52 Week High 3,521.50p
52 Week Low 2,683.00p
Volume 1,587,217
Shares Issued 1,252.09m
Market Cap £40,699m
Beta 0.69
RiskGrade 77

AstraZeneca Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
74.31% above the market average74.31% above the market average74.31% above the market average74.31% above the market average74.31% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
Price Trend
31.64% above the market average31.64% above the market average31.64% above the market average31.64% above the market average31.64% above the market average
32.00% above the sector average32.00% above the sector average32.00% above the sector average32.00% above the sector average32.00% above the sector average
Income
93.64% above the market average93.64% above the market average93.64% above the market average93.64% above the market average93.64% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
Growth
94.14% below the market average94.14% below the market average94.14% below the market average94.14% below the market average94.14% below the market average
89.74% below the sector average89.74% below the sector average89.74% below the sector average89.74% below the sector average89.74% below the sector average

What The Brokers Say

Strong Buy 3
Buy 0
Neutral 22
Sell 4
Strong Sell 7
Total 36
neutral
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

AstraZeneca Dividends

  Latest Previous
  2nd Interim 1st Interim
Ex-Div 13-Feb-13 08-Aug-12
Paid 18-Mar-13 10-Sep-12
Amount 190.00¢ 90.00¢

Trades for 18-Jun-2013

Time Volume / Share Price
16:58 5,698 @ 3,249.57p
16:44 13,283 @ 3,248.63p
16:44 5,970 @ 3,254.52p
16:35 93 @ 3,250.50p
16:35 326,677 @ 3,250.50p

AstraZeneca Key Personnel

CEO Pascal Soriot

Top of Page